ESG

A prestigious Yale recognition for board member Dr. Curtis Patton bolsters Tevogen's credibility as it advances its AI and T-cell platforms.

A new platform lets your idle devices earn Bitcoin. Is this a futuristic lifestyle trend for luxury living or just a volatile digital experiment?

Beyond bureaucracy, a federal push for bilingual services aims to dismantle linguistic barriers, impacting health equity for minority communities across Canada.

A landmark deal between Airspan and Rakuten, backed by US funds, marks a new era for open networks, challenging the global telecom supply chain.

PathAI's AIM-MASH tool just got dual FDA/EMA approval, a first for AI pathology. This could slash MASH drug development time and reshape clinical trials.

Ekinops unveils its C700HC chassis, a hybrid system designed to unify telecom offices and data centers, tackling the massive bandwidth demands of AI.

Beyond a tagline, The Aesthetic Society is expanding to include non-surgeons, a strategic move to set standards and consolidate influence in a booming market.

Abundia Global Impact Group and Alterra Energy are building a major plastics-to-fuel facility, a bold move to reshape the Gulf Coast's energy landscape.

A newly validated 'longevity protein' is fueling a biotech gold rush, but can companies turn breakthrough science into viable medicine? An inside look.

A $170M deal to boost infant formula supply has soured for Perrigo, leading to a 25% stock crash, a strategic review, and securities fraud lawsuits.

Regenerative Patch Technologies advances its stem cell therapy for dry AMD, signaling a potential shift from merely slowing blindness to actively improving vision.

Hyatt's new safari partnership isn't just a perk; it's a strategic move into purpose-driven travel, redefining luxury loyalty for a new era.

A $2.4B tech acquisition seems distant from healthcare, but Qualcomm's move to buy Alphawave is building the essential AI infrastructure for medicine's future.

A North Carolina hospital is the first to deploy Mako robotics for shoulder surgery, using AI and haptic tech to offer unprecedented surgical accuracy.

An Atlanta clinic's top award highlights a market shift toward minimally invasive fibroid treatment and a crucial fight for health equity in women's care.

With a new M&A-savvy CRO and Blackstone's backing, Enverus is poised for aggressive growth, aiming to dominate the AI-driven future of energy intelligence.

One company's move to standardize a traditional remedy highlights a key strategy for winning trust and market share in the booming wellness industry.

BayWa r.e.'s new solar and storage park is more than infrastructure; it's a blueprint for financing, grid stability, and navigating complex community politics.

A Chinese firm's entry into Germany's EV market seems distant from medicine, but its tricycle vehicle could be the key to a greener, faster last-mile for healthcare.

A new oral drug could eliminate the dangerous side effects of CAR T-Cell therapy, potentially making the breakthrough cancer treatment safer and more accessible.